Global Neuromodulation Devices Market Report 2019, Competitive Landscape, Trends and Opportunities
The Neuromodulation Devices market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Neuromodulation Devices market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Neuromodulation Devices market.
Major players in the global Neuromodulation Devices market include:
BioControl Medical
Neuronetics
Neuropace
Cyberonics
Synapse Biomedical
Medtronic
Boston Scientific Corporation
Nevro
Neurosigma
St.Jude Medical
On the basis of types, the Neuromodulation Devices market is primarily split into:
Deep Brain Stimulation (DBS) Systems
Spinal Cord Stimulator (SCS) Systems
Diaphragm Pacing System (DPS)
Respiratory Electrical Stimulation (RES)
Vagus Nerve Stimulation (VNS)
Gastric Electrical Stimulation (GES)
Transcranial Magnetic Stimulation (TMS)
Transcutaneous Electrical Nerve Stimulation (TENS)
On the basis of applications, the market covers:
Chronic Pain
Parkinson's Disease
Urinary Fecal Incontinence
Refractory Epilepsy
Essential Tremor
Dystonia
Gastroparesis
Treatment-Resistant Depression (TRD)
Obsessive Compulsive Disorder (OCD)
Other Applications
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Neuromodulation Devices market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Neuromodulation Devices market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Neuromodulation Devices industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Neuromodulation Devices market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Neuromodulation Devices, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Neuromodulation Devices in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Neuromodulation Devices in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Neuromodulation Devices. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Neuromodulation Devices market, including the global production and revenue forecast, regional forecast. It also foresees the Neuromodulation Devices market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
The report mainly studies the size, recent trends and development status of the Neuromodulation Devices market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Neuromodulation Devices market.
Major players in the global Neuromodulation Devices market include:
BioControl Medical
Neuronetics
Neuropace
Cyberonics
Synapse Biomedical
Medtronic
Boston Scientific Corporation
Nevro
Neurosigma
St.Jude Medical
On the basis of types, the Neuromodulation Devices market is primarily split into:
Deep Brain Stimulation (DBS) Systems
Spinal Cord Stimulator (SCS) Systems
Diaphragm Pacing System (DPS)
Respiratory Electrical Stimulation (RES)
Vagus Nerve Stimulation (VNS)
Gastric Electrical Stimulation (GES)
Transcranial Magnetic Stimulation (TMS)
Transcutaneous Electrical Nerve Stimulation (TENS)
On the basis of applications, the market covers:
Chronic Pain
Parkinson's Disease
Urinary Fecal Incontinence
Refractory Epilepsy
Essential Tremor
Dystonia
Gastroparesis
Treatment-Resistant Depression (TRD)
Obsessive Compulsive Disorder (OCD)
Other Applications
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Neuromodulation Devices market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Neuromodulation Devices market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Neuromodulation Devices industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Neuromodulation Devices market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Neuromodulation Devices, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Neuromodulation Devices in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Neuromodulation Devices in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Neuromodulation Devices. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Neuromodulation Devices market, including the global production and revenue forecast, regional forecast. It also foresees the Neuromodulation Devices market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
Historical Years: 2014-2018
Base Year: 2019
Estimated Year: 2019
Forecast Period: 2019-2026
1 NEUROMODULATION DEVICES MARKET OVERVIEW
1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Neuromodulation Devices Segment by Type
1.2.1 Global Neuromodulation Devices Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Deep Brain Stimulation (DBS) Systems
1.2.3 The Market Profile of Spinal Cord Stimulator (SCS) Systems
1.2.4 The Market Profile of Diaphragm Pacing System (DPS)
1.2.5 The Market Profile of Respiratory Electrical Stimulation (RES)
1.2.6 The Market Profile of Vagus Nerve Stimulation (VNS)
1.2.7 The Market Profile of Gastric Electrical Stimulation (GES)
1.2.8 The Market Profile of Transcranial Magnetic Stimulation (TMS)
1.2.9 The Market Profile of Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 Global Neuromodulation Devices Segment by Application
1.3.1 Neuromodulation Devices Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Chronic Pain
1.3.3 The Market Profile of Parkinson's Disease
1.3.4 The Market Profile of Urinary Fecal Incontinence
1.3.5 The Market Profile of Refractory Epilepsy
1.3.6 The Market Profile of Essential Tremor
1.3.7 The Market Profile of Dystonia
1.3.8 The Market Profile of Gastroparesis
1.3.9 The Market Profile of Treatment-Resistant Depression (TRD)
1.3.10 The Market Profile of Obsessive Compulsive Disorder (OCD)
1.3.11 The Market Profile of Other Applications
1.4 Global Neuromodulation Devices Market by Region (2014-2026)
1.4.1 Global Neuromodulation Devices Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3 Europe Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.1 Germany Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.2 UK Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.3 France Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.4 Italy Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.5 Spain Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.6 Russia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.7 Poland Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.4 China Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.5 Japan Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.6 India Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8 Central and South America Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Neuromodulation Devices Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Neuromodulation Devices (2014-2026)
1.5.1 Global Neuromodulation Devices Revenue Status and Outlook (2014-2026)
1.5.2 Global Neuromodulation Devices Production Status and Outlook (2014-2026)
2 GLOBAL NEUROMODULATION DEVICES MARKET LANDSCAPE BY PLAYER
2.1 Global Neuromodulation Devices Production and Share by Player (2014-2019)
2.2 Global Neuromodulation Devices Revenue and Market Share by Player (2014-2019)
2.3 Global Neuromodulation Devices Average Price by Player (2014-2019)
2.4 Neuromodulation Devices Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Neuromodulation Devices Market Competitive Situation and Trends
2.5.1 Neuromodulation Devices Market Concentration Rate
2.5.2 Neuromodulation Devices Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 BioControl Medical
3.1.1 BioControl Medical Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Neuromodulation Devices Product Profiles, Application and Specification
3.1.3 BioControl Medical Neuromodulation Devices Market Performance (2014-2019)
3.1.4 BioControl Medical Business Overview
3.2 Neuronetics
3.2.1 Neuronetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Neuromodulation Devices Product Profiles, Application and Specification
3.2.3 Neuronetics Neuromodulation Devices Market Performance (2014-2019)
3.2.4 Neuronetics Business Overview
3.3 Neuropace
3.3.1 Neuropace Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Neuromodulation Devices Product Profiles, Application and Specification
3.3.3 Neuropace Neuromodulation Devices Market Performance (2014-2019)
3.3.4 Neuropace Business Overview
3.4 Cyberonics
3.4.1 Cyberonics Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Neuromodulation Devices Product Profiles, Application and Specification
3.4.3 Cyberonics Neuromodulation Devices Market Performance (2014-2019)
3.4.4 Cyberonics Business Overview
3.5 Synapse Biomedical
3.5.1 Synapse Biomedical Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Neuromodulation Devices Product Profiles, Application and Specification
3.5.3 Synapse Biomedical Neuromodulation Devices Market Performance (2014-2019)
3.5.4 Synapse Biomedical Business Overview
3.6 Medtronic
3.6.1 Medtronic Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Neuromodulation Devices Product Profiles, Application and Specification
3.6.3 Medtronic Neuromodulation Devices Market Performance (2014-2019)
3.6.4 Medtronic Business Overview
3.7 Boston Scientific Corporation
3.7.1 Boston Scientific Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Neuromodulation Devices Product Profiles, Application and Specification
3.7.3 Boston Scientific Corporation Neuromodulation Devices Market Performance (2014-2019)
3.7.4 Boston Scientific Corporation Business Overview
3.8 Nevro
3.8.1 Nevro Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Neuromodulation Devices Product Profiles, Application and Specification
3.8.3 Nevro Neuromodulation Devices Market Performance (2014-2019)
3.8.4 Nevro Business Overview
3.9 Neurosigma
3.9.1 Neurosigma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Neuromodulation Devices Product Profiles, Application and Specification
3.9.3 Neurosigma Neuromodulation Devices Market Performance (2014-2019)
3.9.4 Neurosigma Business Overview
3.10 St.Jude Medical
3.10.1 St.Jude Medical Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Neuromodulation Devices Product Profiles, Application and Specification
3.10.3 St.Jude Medical Neuromodulation Devices Market Performance (2014-2019)
3.10.4 St.Jude Medical Business Overview
4 GLOBAL NEUROMODULATION DEVICES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Neuromodulation Devices Production and Market Share by Type (2014-2019)
4.2 Global Neuromodulation Devices Revenue and Market Share by Type (2014-2019)
4.3 Global Neuromodulation Devices Price by Type (2014-2019)
4.4 Global Neuromodulation Devices Production Growth Rate by Type (2014-2019)
4.4.1 Global Neuromodulation Devices Production Growth Rate of Deep Brain Stimulation (DBS) Systems (2014-2019)
4.4.2 Global Neuromodulation Devices Production Growth Rate of Spinal Cord Stimulator (SCS) Systems (2014-2019)
4.4.3 Global Neuromodulation Devices Production Growth Rate of Diaphragm Pacing System (DPS) (2014-2019)
4.4.4 Global Neuromodulation Devices Production Growth Rate of Respiratory Electrical Stimulation (RES) (2014-2019)
4.4.5 Global Neuromodulation Devices Production Growth Rate of Vagus Nerve Stimulation (VNS) (2014-2019)
4.4.6 Global Neuromodulation Devices Production Growth Rate of Gastric Electrical Stimulation (GES) (2014-2019)
4.4.7 Global Neuromodulation Devices Production Growth Rate of Transcranial Magnetic Stimulation (TMS) (2014-2019)
4.4.8 Global Neuromodulation Devices Production Growth Rate of Transcutaneous Electrical Nerve Stimulation (TENS) (2014-2019)
5 GLOBAL NEUROMODULATION DEVICES MARKET ANALYSIS BY APPLICATION
5.1 Global Neuromodulation Devices Consumption and Market Share by Application (2014-2019)
5.2 Global Neuromodulation Devices Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Neuromodulation Devices Consumption Growth Rate of Chronic Pain (2014-2019)
5.2.2 Global Neuromodulation Devices Consumption Growth Rate of Parkinson's Disease (2014-2019)
5.2.3 Global Neuromodulation Devices Consumption Growth Rate of Urinary Fecal Incontinence (2014-2019)
5.2.4 Global Neuromodulation Devices Consumption Growth Rate of Refractory Epilepsy (2014-2019)
5.2.5 Global Neuromodulation Devices Consumption Growth Rate of Essential Tremor (2014-2019)
5.2.6 Global Neuromodulation Devices Consumption Growth Rate of Dystonia (2014-2019)
5.2.7 Global Neuromodulation Devices Consumption Growth Rate of Gastroparesis (2014-2019)
5.2.8 Global Neuromodulation Devices Consumption Growth Rate of Treatment-Resistant Depression (TRD) (2014-2019)
5.2.9 Global Neuromodulation Devices Consumption Growth Rate of Obsessive Compulsive Disorder (OCD) (2014-2019)
5.2.10 Global Neuromodulation Devices Consumption Growth Rate of Other Applications (2014-2019)
6 GLOBAL NEUROMODULATION DEVICES PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Neuromodulation Devices Consumption by Region (2014-2019)
6.2 United States Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.3 Europe Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.4 China Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.5 Japan Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.6 India Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
7 GLOBAL NEUROMODULATION DEVICES PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Neuromodulation Devices Production and Market Share by Region (2014-2019)
7.2 Global Neuromodulation Devices Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
8 NEUROMODULATION DEVICES MANUFACTURING ANALYSIS
8.1 Neuromodulation Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Neuromodulation Devices
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Neuromodulation Devices Industrial Chain Analysis
9.2 Raw Materials Sources of Neuromodulation Devices Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Neuromodulation Devices
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL NEUROMODULATION DEVICES MARKET FORECAST (2019-2026)
11.1 Global Neuromodulation Devices Production, Revenue Forecast (2019-2026)
11.1.1 Global Neuromodulation Devices Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Neuromodulation Devices Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Neuromodulation Devices Price and Trend Forecast (2019-2026)
11.2 Global Neuromodulation Devices Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Neuromodulation Devices Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Neuromodulation Devices Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Neuromodulation Devices
1.2 Neuromodulation Devices Segment by Type
1.2.1 Global Neuromodulation Devices Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Deep Brain Stimulation (DBS) Systems
1.2.3 The Market Profile of Spinal Cord Stimulator (SCS) Systems
1.2.4 The Market Profile of Diaphragm Pacing System (DPS)
1.2.5 The Market Profile of Respiratory Electrical Stimulation (RES)
1.2.6 The Market Profile of Vagus Nerve Stimulation (VNS)
1.2.7 The Market Profile of Gastric Electrical Stimulation (GES)
1.2.8 The Market Profile of Transcranial Magnetic Stimulation (TMS)
1.2.9 The Market Profile of Transcutaneous Electrical Nerve Stimulation (TENS)
1.3 Global Neuromodulation Devices Segment by Application
1.3.1 Neuromodulation Devices Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Chronic Pain
1.3.3 The Market Profile of Parkinson's Disease
1.3.4 The Market Profile of Urinary Fecal Incontinence
1.3.5 The Market Profile of Refractory Epilepsy
1.3.6 The Market Profile of Essential Tremor
1.3.7 The Market Profile of Dystonia
1.3.8 The Market Profile of Gastroparesis
1.3.9 The Market Profile of Treatment-Resistant Depression (TRD)
1.3.10 The Market Profile of Obsessive Compulsive Disorder (OCD)
1.3.11 The Market Profile of Other Applications
1.4 Global Neuromodulation Devices Market by Region (2014-2026)
1.4.1 Global Neuromodulation Devices Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3 Europe Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.1 Germany Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.2 UK Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.3 France Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.4 Italy Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.5 Spain Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.6 Russia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.3.7 Poland Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.4 China Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.5 Japan Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.6 India Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8 Central and South America Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Neuromodulation Devices Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Neuromodulation Devices Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Neuromodulation Devices (2014-2026)
1.5.1 Global Neuromodulation Devices Revenue Status and Outlook (2014-2026)
1.5.2 Global Neuromodulation Devices Production Status and Outlook (2014-2026)
2 GLOBAL NEUROMODULATION DEVICES MARKET LANDSCAPE BY PLAYER
2.1 Global Neuromodulation Devices Production and Share by Player (2014-2019)
2.2 Global Neuromodulation Devices Revenue and Market Share by Player (2014-2019)
2.3 Global Neuromodulation Devices Average Price by Player (2014-2019)
2.4 Neuromodulation Devices Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Neuromodulation Devices Market Competitive Situation and Trends
2.5.1 Neuromodulation Devices Market Concentration Rate
2.5.2 Neuromodulation Devices Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 BioControl Medical
3.1.1 BioControl Medical Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Neuromodulation Devices Product Profiles, Application and Specification
3.1.3 BioControl Medical Neuromodulation Devices Market Performance (2014-2019)
3.1.4 BioControl Medical Business Overview
3.2 Neuronetics
3.2.1 Neuronetics Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Neuromodulation Devices Product Profiles, Application and Specification
3.2.3 Neuronetics Neuromodulation Devices Market Performance (2014-2019)
3.2.4 Neuronetics Business Overview
3.3 Neuropace
3.3.1 Neuropace Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Neuromodulation Devices Product Profiles, Application and Specification
3.3.3 Neuropace Neuromodulation Devices Market Performance (2014-2019)
3.3.4 Neuropace Business Overview
3.4 Cyberonics
3.4.1 Cyberonics Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Neuromodulation Devices Product Profiles, Application and Specification
3.4.3 Cyberonics Neuromodulation Devices Market Performance (2014-2019)
3.4.4 Cyberonics Business Overview
3.5 Synapse Biomedical
3.5.1 Synapse Biomedical Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Neuromodulation Devices Product Profiles, Application and Specification
3.5.3 Synapse Biomedical Neuromodulation Devices Market Performance (2014-2019)
3.5.4 Synapse Biomedical Business Overview
3.6 Medtronic
3.6.1 Medtronic Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Neuromodulation Devices Product Profiles, Application and Specification
3.6.3 Medtronic Neuromodulation Devices Market Performance (2014-2019)
3.6.4 Medtronic Business Overview
3.7 Boston Scientific Corporation
3.7.1 Boston Scientific Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Neuromodulation Devices Product Profiles, Application and Specification
3.7.3 Boston Scientific Corporation Neuromodulation Devices Market Performance (2014-2019)
3.7.4 Boston Scientific Corporation Business Overview
3.8 Nevro
3.8.1 Nevro Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Neuromodulation Devices Product Profiles, Application and Specification
3.8.3 Nevro Neuromodulation Devices Market Performance (2014-2019)
3.8.4 Nevro Business Overview
3.9 Neurosigma
3.9.1 Neurosigma Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Neuromodulation Devices Product Profiles, Application and Specification
3.9.3 Neurosigma Neuromodulation Devices Market Performance (2014-2019)
3.9.4 Neurosigma Business Overview
3.10 St.Jude Medical
3.10.1 St.Jude Medical Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Neuromodulation Devices Product Profiles, Application and Specification
3.10.3 St.Jude Medical Neuromodulation Devices Market Performance (2014-2019)
3.10.4 St.Jude Medical Business Overview
4 GLOBAL NEUROMODULATION DEVICES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Neuromodulation Devices Production and Market Share by Type (2014-2019)
4.2 Global Neuromodulation Devices Revenue and Market Share by Type (2014-2019)
4.3 Global Neuromodulation Devices Price by Type (2014-2019)
4.4 Global Neuromodulation Devices Production Growth Rate by Type (2014-2019)
4.4.1 Global Neuromodulation Devices Production Growth Rate of Deep Brain Stimulation (DBS) Systems (2014-2019)
4.4.2 Global Neuromodulation Devices Production Growth Rate of Spinal Cord Stimulator (SCS) Systems (2014-2019)
4.4.3 Global Neuromodulation Devices Production Growth Rate of Diaphragm Pacing System (DPS) (2014-2019)
4.4.4 Global Neuromodulation Devices Production Growth Rate of Respiratory Electrical Stimulation (RES) (2014-2019)
4.4.5 Global Neuromodulation Devices Production Growth Rate of Vagus Nerve Stimulation (VNS) (2014-2019)
4.4.6 Global Neuromodulation Devices Production Growth Rate of Gastric Electrical Stimulation (GES) (2014-2019)
4.4.7 Global Neuromodulation Devices Production Growth Rate of Transcranial Magnetic Stimulation (TMS) (2014-2019)
4.4.8 Global Neuromodulation Devices Production Growth Rate of Transcutaneous Electrical Nerve Stimulation (TENS) (2014-2019)
5 GLOBAL NEUROMODULATION DEVICES MARKET ANALYSIS BY APPLICATION
5.1 Global Neuromodulation Devices Consumption and Market Share by Application (2014-2019)
5.2 Global Neuromodulation Devices Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Neuromodulation Devices Consumption Growth Rate of Chronic Pain (2014-2019)
5.2.2 Global Neuromodulation Devices Consumption Growth Rate of Parkinson's Disease (2014-2019)
5.2.3 Global Neuromodulation Devices Consumption Growth Rate of Urinary Fecal Incontinence (2014-2019)
5.2.4 Global Neuromodulation Devices Consumption Growth Rate of Refractory Epilepsy (2014-2019)
5.2.5 Global Neuromodulation Devices Consumption Growth Rate of Essential Tremor (2014-2019)
5.2.6 Global Neuromodulation Devices Consumption Growth Rate of Dystonia (2014-2019)
5.2.7 Global Neuromodulation Devices Consumption Growth Rate of Gastroparesis (2014-2019)
5.2.8 Global Neuromodulation Devices Consumption Growth Rate of Treatment-Resistant Depression (TRD) (2014-2019)
5.2.9 Global Neuromodulation Devices Consumption Growth Rate of Obsessive Compulsive Disorder (OCD) (2014-2019)
5.2.10 Global Neuromodulation Devices Consumption Growth Rate of Other Applications (2014-2019)
6 GLOBAL NEUROMODULATION DEVICES PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Neuromodulation Devices Consumption by Region (2014-2019)
6.2 United States Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.3 Europe Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.4 China Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.5 Japan Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.6 India Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Neuromodulation Devices Production, Consumption, Export, Import (2014-2019)
7 GLOBAL NEUROMODULATION DEVICES PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Neuromodulation Devices Production and Market Share by Region (2014-2019)
7.2 Global Neuromodulation Devices Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Neuromodulation Devices Production, Revenue, Price and Gross Margin (2014-2019)
8 NEUROMODULATION DEVICES MANUFACTURING ANALYSIS
8.1 Neuromodulation Devices Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Neuromodulation Devices
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Neuromodulation Devices Industrial Chain Analysis
9.2 Raw Materials Sources of Neuromodulation Devices Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Neuromodulation Devices
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter?s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL NEUROMODULATION DEVICES MARKET FORECAST (2019-2026)
11.1 Global Neuromodulation Devices Production, Revenue Forecast (2019-2026)
11.1.1 Global Neuromodulation Devices Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Neuromodulation Devices Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Neuromodulation Devices Price and Trend Forecast (2019-2026)
11.2 Global Neuromodulation Devices Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Neuromodulation Devices Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Neuromodulation Devices Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Neuromodulation Devices Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
